Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
Authors
Keywords
-
Journal
BMC Endocrine Disorders
Volume 10, Issue 1, Pages -
Publisher
Springer Nature
Online
2010-06-19
DOI
10.1186/1472-6823-10-10
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cabergoline therapy and the risk of cardiac valve regurgitation in patients with hyperprolactinemia: A metaanalysis from clinical studies
- (2014) F. Bogazzi et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Prevalence of Valvular Heart Disease in a Cohort of Patients Taking Cabergoline for Management of Hyperprolactinemia
- (2013) Jessica Devin et al. Endocrine Practice
- Valvular heart disease and the use of cabergoline for the treatment of prolactinoma
- (2009) Neil Herring et al. CLINICAL ENDOCRINOLOGY
- Gender effects on cardiac valvular function in hyperprolactinaemic patients receiving cabergoline: a retrospective study
- (2009) Lisa B. Nachtigall et al. CLINICAL ENDOCRINOLOGY
- Merits and pitfalls of mifepristone in Cushing's syndrome
- (2009) F Castinetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Coexpression of Dopamine and Somatostatin Receptor Subtypes in Corticotroph Adenomas
- (2009) Christiaan de Bruin et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GAMMA KNIFE RADIOSURGERY FOR ACROMEGALY
- (2009) Jay Jagannathan et al. NEUROSURGERY
- Octreotide LARvs.surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study
- (2008) Annamaria Colao et al. CLINICAL ENDOCRINOLOGY
- Cabergoline and the risk of valvular lesions in endocrine disease.
- (2008) Patrizio Lancellotti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Low dose cabergoline for hyperprolactinaemia is not associated with clinically significant valvular heart disease
- (2008) Ammar Wakil et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Ketoconazole revisited: a preoperative or postoperative treatment in Cushing's disease
- (2008) F Castinetti et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Somatostatinergic ligands in dopamine-sensitive and -resistant prolactinomas
- (2008) Alessandra Fusco et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Treatment with low doses of cabergoline is not associated with increased prevalence of cardiac valve regurgitation in patients with hyperprolactinaemia
- (2008) F. Bogazzi et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Growth Hormone-Secreting Tumor Shrinkage after 3 Months of Octreotide-Long-Acting Release Therapy Predicts the Response at 12 Months
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Quality of Life in Acromegalic Patients during Long-Term Somatostatin Analog Treatment with and without Pegvisomant
- (2008) S. J. C. M. M. Neggers et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Lipodystrophy in Patients with Acromegaly Receiving Pegvisomant
- (2008) Vivien S. Bonert et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Aortic Valve Calcification and Mild Tricuspid Regurgitation But No Clinical Heart Disease after 8 Years of Dopamine Agonist Therapy for Prolactinoma
- (2008) Marleen Kars et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Increased Prevalence of Tricuspid Regurgitation in Patients with Prolactinomas Chronically Treated with Cabergoline
- (2008) Annamaria Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Adrenocorticotropin-Dependent Cushing’s Syndrome: A Consensus Statement
- (2008) B. M. K. Biller et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Treatment of Pituitary-Dependent Cushing’s Disease with the Multireceptor Ligand Somatostatin Analog Pasireotide (SOM230): A Multicenter, Phase II Trial
- (2008) M. Boscaro et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Medical Treatment of Cushing’s Disease: Effectiveness of Chronic Treatment with the Dopamine Agonist Cabergoline in Patients Unsuccessfully Treated by Surgery
- (2008) Rosario Pivonello et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas
- (2008) Sophie Vallette et al. Pituitary
- Pasireotide (SOM230): Development, mechanism of action and potential applications
- (2007) Herbert A. Schmid MOLECULAR AND CELLULAR ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation